Back to Results
First PageMeta Content
Developmental biology / Pregnancy / Obstetrics / Neural tube defect / Spina bifida / Elevated alpha-fetoprotein / Amniocentesis / Anencephaly / Down syndrome / Medicine / Health / Biology


ASHG Policy Statement on Maternal Serum Alpha-Fetoprotein Screening Programs and Quality Control for Laboratories Performing Maternal Serum and Amniotic Fluid Alpha-Fetoprotein Assays
Add to Reading List

Document Date: 2012-02-27 11:17:50

Open Document

File Size: 813,94 KB

Share Result on Facebook

Company

MSAFP AND AFAFP TESTING LABORATORIES The / Pregnancy Subgroup / MSAFP AND AFAFP TESTING LABORATORIES / /

Country

United States / Canada / United Kingdom / /

Currency

USD / /

Facility

American College of Obstetricians / laboratory Criteria / /

IndustryTerm

potential applications / biotechnology / biomedical technology / /

MedicalCondition

neural tube defects / insulindependent diabetes mellitus / disease / midline birth defects / imminent miscarriages / qualitative gel AChE / chromosomal trisomic disorders / serious birth defect / AChE / open spina bifida cystica / open neural tube defects / open neural tube defect / primarily neural tube defects / anencephaly / IDDM / Down syndrome / /

MedicalTreatment

counseling / /

Organization

Genetic Services Committee / American Society of Human Genetics / American Society of Human Genetics Policy Statement for Maternal Serum Alpha-Fetoprotein Screening Programs and Quality Control for Laboratories Performing Maternal Serum / ASHG Public Policy Committee / Social Issues Committee / the American College / /

Person

James N. Macri / Jessica Davis / Neil A. Holtzman / Maurice J. Mahoney / Frank Greenberg / Kenneth L. Garver / Phillip R. Reilly / Anita M. Hagins / George J. Knight / Aubrey Milunsky / Charles R. Scriver / Susan R. Panny / Herbert A. Lubs / /

Position

physician / /

Technology

Alpha / Screening protocols / biotechnology / ultrasound / developing biomedical technology / gel electrophoresis / /

SocialTag